Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP92303.RAr6q4t786YxvOZTewrAsNgFONqWejlHRpkaxXwiLDMBo130_assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92303.RAr6q4t786YxvOZTewrAsNgFONqWejlHRpkaxXwiLDMBo130_provenance.
• NP86460.RA_ydn9qD9oiFJwCYxUx_nTOU-QUYVm5XYkHxrysovq5M130_assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86460.RA_ydn9qD9oiFJwCYxUx_nTOU-QUYVm5XYkHxrysovq5M130_provenance.
• NP87280.RAdks4C0aoHf_hc4aVraULfxQrujdDZSwoRpnjW5M6yeY130_assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87280.RAdks4C0aoHf_hc4aVraULfxQrujdDZSwoRpnjW5M6yeY130_provenance.
• NP84026.RAQ7IVqeu00hI6aFJ2fOkmGIx8VqL0R31TCf0gXi5kPQ8130_assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84026.RAQ7IVqeu00hI6aFJ2fOkmGIx8VqL0R31TCf0gXi5kPQ8130_provenance.
• NP92301.RAPciSCdFLIHoQ0lvnlH24IzHvpL6Q9T8Tdutq5KiAga0130_assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92301.RAPciSCdFLIHoQ0lvnlH24IzHvpL6Q9T8Tdutq5KiAga0130_provenance.
• assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP136224.RAJ3KXk07pPU2BBsjsCZZkucEG9FeZaeKlY1z-T1-iSL0130_assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP136224.RAJ3KXk07pPU2BBsjsCZZkucEG9FeZaeKlY1z-T1-iSL0130_provenance.
• assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP138454.RAvElxVWICXyFv53cN8w8anv3zjBS6JiBDifMfpO0qEik130_assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP138454.RAvElxVWICXyFv53cN8w8anv3zjBS6JiBDifMfpO0qEik130_provenance.
• assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP183920.RAD_6ZHNYkv60EAD3UuzdqYoxwhYDMATtieN_GSWbbKn0130_assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183920.RAD_6ZHNYkv60EAD3UuzdqYoxwhYDMATtieN_GSWbbKn0130_provenance.
• NP183922.RAXm5lEzs9su1VoIL_cHDXOXHCu3QDQ-N9yYffl5X9Gag130_assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183922.RAXm5lEzs9su1VoIL_cHDXOXHCu3QDQ-N9yYffl5X9Gag130_provenance.
• NP183923.RAlmXMP_7b-8oiFp-60_DIsNSV80lJpMqsbQlzvpVPL68130_assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183923.RAlmXMP_7b-8oiFp-60_DIsNSV80lJpMqsbQlzvpVPL68130_provenance.
• NP183924.RAquhpN90a3UZn6dXyZwv_LhDfdCgj-LhbsQImKVvMP88130_assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183924.RAquhpN90a3UZn6dXyZwv_LhDfdCgj-LhbsQImKVvMP88130_provenance.
• NP149841.RA8Rtqn7MObPaC833TCV9UFAi69dKGcXdV4lNSsjZc1eM130_assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP149841.RA8Rtqn7MObPaC833TCV9UFAi69dKGcXdV4lNSsjZc1eM130_provenance.
• NP130049.RA3K2U8KfCkGzxRIS9Cd6-nJhAETS9j8ZFEYikMJC84y8130_assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130049.RA3K2U8KfCkGzxRIS9Cd6-nJhAETS9j8ZFEYikMJC84y8130_provenance.
• NP149843.RAOxFC7_pmQZHrhqQIsFgvD3Mdh6tC9qAFx57klG8IqWg130_assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP149843.RAOxFC7_pmQZHrhqQIsFgvD3Mdh6tC9qAFx57klG8IqWg130_provenance.
• NP183925.RA2SBHcyrfLiMoC09qzgs7YhJ4if9gRiazuuISwlbD4F0130_assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183925.RA2SBHcyrfLiMoC09qzgs7YhJ4if9gRiazuuISwlbD4F0130_provenance.